PharmaSil: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PharmaSil
Largest movements
- Cash +€75,842
up €75,842 (+92.8%), from €81,734 to €157,576
mainly Net result for the year (+€133,126) and Depreciation (+€46,838)
- Intangible fixed assets -€30,000
down €30,000 (-10.8%), from €277,459 to €247,459
- Tangible fixed assets -€13,893
down €13,893 (-19.0%), from €73,161 to €59,268
of which Furniture and vehicles: -€10,538
- Receivables within one year +€10,134
up €10,134 (+10.9%), from €93,383 to €103,517
of which Trade receivables: +€13,555
- Reserves +€133,126
up €133,126 (+135.7%), from €98,122 to €231,248
- Other debts -€80,704
down €80,704 (-19.0%), from €423,973 to €343,269
- Trade debts -€7,991
down €7,991 (-12.7%), from €62,765 to €54,775
- Gross operating margin +€105,085
up €105,085 (+59.8%), from €175,805 to €280,891
- Staff costs +€44,701
new in 2025: €44,701
- Depreciation +€15,702
up €15,702 (+50.4%), from €31,137 to €46,838
- Taxes +€10,202
up €10,202 (+21.8%), from €46,722 to €56,924
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €607,095 | €648,028 | +€40,933 | +6.7% |
| Fixed assets | 21/28 | €350,620 | €306,727 | -€43,893 | -12.5% |
| Intangible fixed assets | 21 | €277,459 | €247,459 | -€30,000 | -10.8% |
| Tangible fixed assets | 22/27 | €73,161 | €59,268 | -€13,893 | -19.0% |
| Plant, machinery and equipment | 23 | €25,492 | €22,137 | -€3,355 | -13.2% |
| Furniture and vehicles | 24 | €47,669 | €37,131 | -€10,538 | -22.1% |
| Current assets | 29/58 | €256,475 | €341,301 | +€84,826 | +33.1% |
| Stocks and contracts in progress | 3 | €77,510 | €76,184 | -€1,326 | -1.7% |
| Stocks | 30/36 | €77,510 | €76,184 | -€1,326 | -1.7% |
| Amounts receivable within one year | 40/41 | €93,383 | €103,517 | +€10,134 | +10.9% |
| Trade receivables | 40 | €89,559 | €103,115 | +€13,555 | +15.1% |
| Other amounts receivable | 41 | €3,824 | €402 | -€3,422 | -89.5% |
| Cash at bank and in hand | 54/58 | €81,734 | €157,576 | +€75,842 | +92.8% |
| Deferred charges and accrued income | 490/1 | €3,847 | €4,024 | +€177 | +4.6% |
| Total equity and liabilities | 10/49 | €607,095 | €648,028 | +€40,933 | +6.7% |
| Equity | 10/15 | €108,122 | €241,248 | +€133,126 | +123.1% |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Reserves | 13 | €98,122 | €231,248 | +€133,126 | +135.7% |
| Distributable reserves | 133 | €98,122 | €231,248 | +€133,126 | +135.7% |
| Amounts payable | 17/49 | €498,973 | €406,780 | -€92,193 | -18.5% |
| Amounts payable within one year | 42/48 | €498,460 | €406,780 | -€91,680 | -18.4% |
| Trade debts | 44 | €62,765 | €54,775 | -€7,991 | -12.7% |
| Suppliers | 440/4 | €62,765 | €54,775 | -€7,991 | -12.7% |
| Taxes, remuneration and social security | 45 | €11,722 | €8,736 | -€2,986 | -25.5% |
| Taxes | 450/3 | €11,722 | €8,736 | -€2,986 | -25.5% |
| Other amounts payable | 47/48 | €423,973 | €343,269 | -€80,704 | -19.0% |
| Accrued charges and deferred income | 492/3 | €513 | - | -€513 | |
| Remuneration, social security and pensions | 62 | - | €44,701 | +€44,701 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €31,137 | €46,838 | +€15,702 | +50.4% |
| Other operating charges | 640/8 | €546 | €697 | +€151 | +27.6% |
| Gross operating margin | 9900 | €175,805 | €280,891 | +€105,085 | +59.8% |
| Operating profit (loss) | 9901 | €144,123 | €188,655 | +€44,532 | +30.9% |
| Financial income | 75/76B | €1,784 | €2,465 | +€681 | +38.2% |
| Recurring financial income | 75 | €1,784 | €2,465 | +€681 | +38.2% |
| Financial charges | 65/66B | €204 | €1,070 | +€867 | +426.0% |
| Recurring financial charges | 65 | €204 | €1,070 | +€867 | +426.0% |
| Profit (loss) for the period before taxes | 9903 | €145,703 | €190,049 | +€44,346 | +30.4% |
| Income taxes | 67/77 | €46,722 | €56,924 | +€10,202 | +21.8% |
| Profit (loss) for the period | 9904 | €98,981 | €133,126 | +€34,145 | +34.5% |
| Profit (loss) for the period to be appropriated | 9905 | €98,981 | €133,126 | +€34,145 | +34.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.